Form D · Other

Empire Medicinals, Inc.

Rochester, NY · CIK 0001697880

Offering snapshot reported Mar 27, 2019 · SEC filing

Reported sold
$160K
Offering amount: $1M
Investors reported
5
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Feb 3, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$80K$160KFeb 17, 2017: $10,000.00Feb 17, 2017Mar 27, 2019: $160,000.00Mar 27, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,000 → $160,000
  • Reported investors1 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 27, 2019Amendment$160,000$150,000vs Feb 17, 20175SEC filing
Feb 17, 2017Initial$10,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-280932

Source: Form D, filed Mar 27, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher K Carter Director, Executive
Andrew Pomeroy Executive
F Scott Valpey Director, Executive
Qiaosong George Zheng Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
125 Tech Park Drive
Rochester, NY, 14623